Want to see TSE:CDVA full AI Analyst Report?
Top Page
CordovaCann
(CDVA)
Select Model
Select Model
Rating:44Neutral
Price Target:
C$0.02
▲(20.00% Upside)
Action:Reiterated
Date:07/30/26
The score is held down primarily by weak profitability and a stressed capital structure (negative equity with meaningful debt), despite improved operating momentum and recently positive free cash flow. Technically, the stock is in a clear downtrend (below all key moving averages) with very high volatility. Valuation offers limited support because the company remains unprofitable and no dividend yield is available.
Positive Factors
Cash generation turnaround
A sustained shift to positive operating and free cash flow (~$0.9M TTM) represents a durable improvement in cash conversion after prior negative years. Over a 2–6 month horizon, reliable cash generation reduces immediate financing needs and supports organic funding for operations and deleveraging if maintained.
Negative Factors
Stressed capital structure
Negative shareholders' equity combined with meaningful debt (~$5.2M TTM) materially weakens financial flexibility. This capital structure elevates refinancing and dilution risk, constrains the ability to invest or absorb shocks, and makes long-term balance sheet repair necessary for sustainable growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation turnaround
A sustained shift to positive operating and free cash flow (~$0.9M TTM) represents a durable improvement in cash conversion after prior negative years. Over a 2–6 month horizon, reliable cash generation reduces immediate financing needs and supports organic funding for operations and deleveraging if maintained.
Read all positive factors
CordovaCann (CDVA) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$2.75M
Dividend YieldN/A
Average Volume (3M)44.87K
Price to Earnings (P/E)―
Beta (1Y)4.51
Revenue Growth-2.84%
EPS Growth-228.77%
CountryCA
Employees45
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.02
Shares Outstanding109,803,460
10 Day Avg. Volume14,141
30 Day Avg. Volume44,872
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-1.04
Price to Sales (P/S)0.42
P/FCF Ratio5.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CordovaCann Business Overview & Revenue Model
Company Description
CordovaCann Corp. is a company that focuses on various aspects of the cannabis industry, including identifying prospects, securing financing, developing new ventures, and managing operations throughout the entire cannabis value chain. As of Februa...
CordovaCann Financial Statement Overview
Summary
Income Statement
26
Negative
Balance Sheet
14
Very Negative
Cash Flow
58
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.72M | 14.25M | 13.80M | 13.59M | 13.53M | 10.32M |
| Gross Profit | 1.83M | 1.55M | 4.08M | 3.86M | 3.73M | 3.49M |
| EBITDA | -1.04M | -817.35K | 493.74K | -4.68M | -1.85M | -2.69M |
| Net Income | -2.64M | -2.69M | -1.49M | -6.88M | -3.96M | -5.15M |
Balance Sheet | ||||||
| Total Assets | 6.38M | 6.41M | 9.55M | 10.26M | 16.75M | 17.27M |
| Cash, Cash Equivalents and Short-Term Investments | 515.15K | 598.20K | 552.47K | 248.42K | 714.83K | 1.06M |
| Total Debt | 5.17M | 5.00M | 6.21M | 6.38M | 6.08M | 5.91M |
| Total Liabilities | 12.13M | 11.61M | 12.15M | 11.29M | 10.16M | 9.96M |
| Stockholders Equity | -6.24M | -5.81M | -3.30M | -1.72M | 5.86M | 6.49M |
Cash Flow | ||||||
| Free Cash Flow | 906.77K | 1.12M | 1.49M | -1.21M | -2.73M | -962.15K |
| Operating Cash Flow | 923.45K | 1.14M | 1.49M | -452.73K | -2.07M | -221.16K |
| Investing Cash Flow | 1.55M | 1.55M | 52.96K | -708.88K | 2.07M | -872.05K |
| Financing Cash Flow | -2.49M | -2.51M | -1.10M | -134.36K | 720.69K | 1.57M |
CordovaCann Technical Analysis
Negative
0.02
Price Trends
0.04
Negative
0.04
Negative
0.03
Negative
Market Momentum
>-0.01
Negative
42.46
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CDVA, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.46 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CDVA.
CordovaCann Peers Comparison
UnderperformOutperform
Sector (51)
TSE:CDVA
CordovaCann
0.03
-0.03
-58.33%
TSE:BBM
Blueberries Medical
0.02
<0.01
50.00%
TSE:BAMM
Body & Mind
0.03
0.00
0.00%
TSE:CVGR
City View Green Holdings
0.03
-0.03
-50.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.